-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11

Benzinga·10/31/2025 20:18:35
Listen to the news
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $12 to $11.